Adcorp (ADR)
Johannesburg Exchange · South Africa · prices in ZAC · close of 23 Oct 2026
Key indicators
| Last close | ZAC 615.00 |
|---|---|
| 52-week range | 514.00 – 749.00 |
| Return, 1 month / 3 months | −1.6% / −5.4% |
| Return, 1 year / 3 years | −15.8% / +31.1% |
| Trend | Below its 200-day average |
| RSI (14) | 49 |
| Volatility (1 year) | 56.3% |
| Worst drawdown (1 year) | -27.0% |
| Average daily value traded | 33.06M ZAC |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Adcorp is a South African provider of staffing and workforce management services. The company supplies temporary, contract and permanent staff to employers, and offers recruitment, outsourcing and related human resources services. Its clients come from a range of industries, including information technology, engineering, finance and general labour, and it operates from South Africa while serving employers that need flexible and managed workforces.
On this site Adcorp appears as a stock on the Johannesburg Exchange (South Africa), code ADR, with prices in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Adcorp (ADR) trades on the Johannesburg Exchange in South Africa. It last closed at ZAC 615.00 on 23 October 2026.
Its price-based Market X-Ray is 35 out of 100 (a weak price profile), ranking 178 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 15.8% and over the last three months it fell 5.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 51 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.0% | ||
| From 52-week high | -17.0% | ||
| Momentum | 25 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -5.4% | ||
| 6-month return | -13.4% | ||
| 12-month return, skipping the last month | -14.4% | ||
| Stability (higher is calmer) | 36 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 56.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.0% | ||
| Liquidity | 27 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 33.06M ZAC | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.8% |
|---|---|
| 1 month | −1.6% |
| 3 months | −5.4% |
| 6 months | −13.4% |
| 1 year | −15.8% |
| 3 years | +31.1% |
| 5 years | +26.1% |
Signals
| 50-day / 200-day average | 623.50 / 627.44 |
|---|---|
| Golden / death cross (60 days) | Death, 5 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 20.40 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Aug 2023 | ZAC 16.5000 |
| 18 Jan 2023 | ZAC 12.2000 |
| 17 Aug 2022 | ZAC 47.0000 |
| 14 Aug 2019 | ZAC 96.1000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.